Clinical Trial Update: Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing mifepristone-misoprostol to misoprostol alone for second-trimester intrauterine fetal demise was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Fetal Demise

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Fetal Death | Phase 3 | Status: TERMINATED